{"id":20651,"date":"2026-02-27T10:39:09","date_gmt":"2026-02-27T10:39:09","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/20651\/"},"modified":"2026-02-27T10:39:09","modified_gmt":"2026-02-27T10:39:09","slug":"ubs-group-discloses-stake-in-european-online-pharmacy-operator-redcare","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/20651\/","title":{"rendered":"UBS Group Discloses Stake in European Online Pharmacy Operator Redcare"},"content":{"rendered":"


\n\t
\n\t\tUBS<\/a>, Group<\/a>\t\t
\n\t\t27.02.2026 – 10:37:04 | boerse-global.de
\n\t <\/p>\n

UBS Group AG reports a routine transaction in Redcare Pharmacy shares, a procedural filing required for transparency, not signaling a strategic change in the online pharmacy sector.<\/p>\n


\n
\n\t\t
\n\t
\n\t\t\t
\n\t
\n\t <\/p>\n

A recent regulatory filing has revealed a transaction involving a major financial institution’s holdings in Redcare Pharmacy N.V. UBS Group AG reported the transaction, which occurred on February 18, in a standard disclosure made public the following day. The Dutch-based company, Redcare Pharmacy, subsequently published the notification without alteration.<\/p>\n

Understanding Shareholding Disclosures<\/p>\n

Such notifications of voting rights are a routine feature of capital market communications, mandated by law to ensure transparency in ownership structures. They are triggered when a shareholder’s stake crosses specific thresholds, either by increasing, decreasing, or reaching a designated percentage. This latest filing represents a procedural update rather than an indication of a strategic shift.<\/p>\n

The Evolving Online Pharmacy Landscape<\/p>\n

The sector for digital pharmacies continues to attract investor attention, driven by broader trends in healthcare digitization and the adoption of electronic prescriptions. Redcare Pharmacy, headquartered in Venlo, the Netherlands, operates across multiple European markets, providing both pharmaceutical products and digital health services.<\/p>\n

Should investors sell immediately? Or is it worth buying Redcare Pharmacy?<\/a><\/p>\n

Market dynamics for companies in this space are largely shaped by regulatory changes and growing consumer acceptance of digital health solutions. The current disclosure from UBS is viewed by market observers as a standard administrative procedure with no immediate implications for Redcare Pharmacy’s day-to-day operations.<\/p>\n

Ad<\/p>\n

Redcare Pharmacy Stock: New Analysis – 27 February<\/p>\n

Fresh Redcare Pharmacy information released. What’s the impact for investors? Our latest independent report examines recent figures and market trends.<\/p>\n

Read our updated Redcare Pharmacy analysis…<\/a><\/p>\n

\t
\n
\n
\n\t <\/p>\n

\t\t Hol dir jetzt den Wissensvorsprung der Aktien-Profis.
\n\t\t\t\t\t\"<\/p>\n

Seit 2005 liefert der B\u00f6rsenbrief trading-notes verl\u00e4ssliche Aktien-Empfehlungen \u2013 dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr.
Jetzt abonnieren<\/a>. <\/a><\/p>\n

\t
\n\t <\/p>\n


\n\t
\n\t\t\t\t\t\tNL0012044747 | UBS | boerse | 68617629\t\t\t\t \n\t<\/p>\n


\n <\/p>\n","protected":false},"excerpt":{"rendered":" UBS, Group 27.02.2026 – 10:37:04 | boerse-global.de UBS Group AG reports a routine transaction…\n","protected":false},"author":2,"featured_media":20652,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[129],"tags":[2942,6023,8620,13730,12177,12176,2944,223],"class_list":{"0":"post-20651","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ubs","8":"tag-discloses","9":"tag-european","10":"tag-group","11":"tag-operator","12":"tag-pharmacy","13":"tag-redcare","14":"tag-stake","15":"tag-ubs"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/20651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=20651"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/20651\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/20652"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=20651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=20651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=20651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}